Table 3. Median Ct values of nasal and saliva specimens stratified by days from symptom onset, and results from the Wilcoxon signed-rank tests for the overall analysis cohort.
n (Pairs) | Nasal VTM | Saliva Direct | Wilcoxon signed-rank test | |||||
---|---|---|---|---|---|---|---|---|
Days since symptom onset | Median | IQR | Median | IQR | Median of differences | Z | p-value | |
Ct | Ct | |||||||
Less than 5 days | 21 | 34.6 | 32.3–50.0 | 32.5 | 26.6–33.9 | 8.7 | 3.02 | 0.003 |
5 to 9 days | 63 | 40.0 | 33.75–50.0 | 35.8 | 30.9–38.7 | 4.0 | 4.58 | < 0.001 |
10 to 14 days | 35 | 50.0 | 39.75–50.0 | 39.4 | 32.85–41.5 | 8.6 | 2.37 | 0.003 |
15 or more days | 28 | 50.0 | 41.88–50.0 | 38.7 | 30.82–50.0 | 6.1 | 3.14 | 0.002 |